www.easy-to-use-pharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Stop Smoking
- Surgery
- Urinary Tract
- Women's Health
Generic Irbesartan - Avalide, Avapro
Generic Avalide
Irbesartan Hydrochlorothiazide 150mg + 12.5mg
Generic Avalide is a combination medication used to treat high blood pressure. One component belongs to a class of blood pressure medications that prevents the hormone angiotensin II from constricting the blood vessels, thereby allowing blood to flow more freely and keeping blood pressure down. The other component is a diuretic that increases the output of urine, removing excess fluid from the body and thus lowering blood pressure.
$1.79
Buy now!
Generic Avapro
Generic Avapro is used for treating high blood pressure. It may be used alone or with other blood pressure medicines.
$1.11
Buy now!
Choose Your language:
- Testimonials
-
I have Received the Order .
Read more »
Reveived the order quick as well ..
Very Inpressed with the time of Delivery - Mike
-
- Teva Reports First Quarter 2012 Results - MarketWatch (press release)
- Proactive Investors USA & CanadaTeva Reports First Quarter 2012 ResultsMarketWatch (press release)Products launched included escitalopram, modafinil, progesterone, irbesartan and irbesartan/HCTZ, quetiapine and olanzapine ODT
- Product launches, Cephalon acquisition drive Teva's Q1 revenues - Drug Store News
- Product launches, Cephalon acquisition drive Teva's Q1 revenuesDrug Store News
- Strong Q1 for Sanofi ahead of challenging nine months - PMLiVE
- The Star-Ledger - NJ
- Generic Plavix debuts in US - PMLiVE
- Generic Plavix debuts in USPMLiVESanofi and BMS are weathering the impact of two major patent expiries each, with BMS set to lose US patent protection for $1
- Sanofi's strong 1st-qtr driven by Genzyme - The Pharma Letter
- Sanofi's strong 1st-qtr driven by GenzymeThe Pharma Letter
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
